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Abstract
An atypical pattern of coagulase-negative staphylococcal (CoNS) sepsis, characterized by persistence despite aggressive antibiotic ther-
apy, has been described in neonates cared for in neonatal intensive-care units. Our aim was to analyse the clinical, microbiological and
molecular determinants of this persistent CoNS bacteraemia. Neonates with late-onset CoNS bacteraemia were studied for a 2-year
period. Demographic, clinical, laboratory, microbiological and molecular data were compared between neonates with persistent (‡3
consecutive positive blood cultures) and non-persistent CoNS bacteraemia. Twenty-nine infants with persistent and 43 with non-persis-
tent bacteraemia were identiﬁed, with no signiﬁcant differences regarding demographic and clinical characteristics between the two
groups. Of a total of 170 CoNS isolates, 80 showed bioﬁlm production (54 persistent and 26 non-persistent; p 0.013), whereas 127
were positive for the icaA and icaD genes (74 persistent and 53 non-persistent; p 0.598). Sixty ica-positive isolates did not produce
slime, whereas 13 ica-negative isolates showed bioﬁlm production. Endotracheal intubation and the presence of central vascular cathe-
ters were signiﬁcant risk factors for persistent bacteraemia, but, in a logistic regression model, only bioﬁlm production was signiﬁcantly
related to the persistent form of the disease (p 0.005). In this study, persistent CoNS sepsis in neonates requiring intensive care was
not related to most of the known clinical risk factors, and it was associated with severe thrombocytopenia. Isolates associated with
persistent bacteraemia were more likely to produce bioﬁlm, independently of the presence of the ica operon.
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Introduction
Coagulase-negative staphylococci have been identiﬁed as the
leading cause of late-onset sepsis in neonatal intensive-care
units (NICUs) [1–4]. Reported risk factors include extreme
prematurity and very low birthweight [5–7], as well as the use
of intravascular catheters [6–8] and prolonged parenteral
nutrition [8–10]. Although most published studies suggest that
coagulase-negative staphylococci have relatively low virulence
and are not associated with signiﬁcant morbidity [2,7,11,12],
atypical outbreaks of persistent bacteraemia despite aggres-
sive antibiotic therapy have also been reported [10,13].
In adults, bioﬁlm formation is considered to be an
important determinant of coagulase-negative staphylococcal
(CoNS) virulence, especially in intravenous catheter or pros-
thetic device-related sepsis [14]. The adherence to prosthetic
material and the subsequent elaboration of the bioﬁlm matrix
(slime) is a complex process [14–16]. One important element
in this process is the ica operon (icaA, icaD, icaB and icaC
genes), encoding polysaccharide intercellular adhesin [16],
which mediates the intercellular adherence of bacteria and
the multilayer accumulation of the bioﬁlm [15,16], rendering
them particularly refractory to antimicrobial agents [16,17]
and to immune functions of the host [18]. Although the rele-
vance of the presence of the ica operon and the production
of slime has been studied previously in neonates [19,20], it is
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unclear whether strains responsible for more persistent
clinical forms of CoNS sepsis possess these determinants.
An atypical pattern of CoNS sepsis characterized by
persistent bacteraemia and signiﬁcant morbidity despite
aggressive antibiotic therapy has been noted in our NICU
during the last 6 years. The aim of this study was to describe
the clinical proﬁle of neonates with this atypical form of the
disease, and to determine whether isolates associated with
persistent CoNS bacteraemia are more likely to possess spe-
ciﬁc molecular determinants, such as the icaA and icaD genes,
and to show bioﬁlm production.
Materials and Methods
Patients and data
This prospective study was performed at the NICU of the
University Hospital of Patras, Greece, a level III referral unit,
from January 2006 to December 2007. All neonates diag-
nosed with late-onset CoNS sepsis, deﬁned as at least one
positive blood culture drawn after 72 h of age in the pres-
ence of signs of infection [4], were eligible for participation
in the study. Persistent CoNS bacteraemia was deﬁned as
three or more consecutive positive blood cultures with the
same CoNS species, at least 48 h apart, during a single septic
episode. All blood samples for culture were obtained by
peripheral venipunctures with a sterile technique after appro-
priate skin disinfection. The study was approved by the
Ethics Committee of the University Hospital of Patras, and
informed consent was obtained from the parents.
Demographic data, including sex, gestational age, birth-
weight, and postnatal age at the onset of septic episode
(deﬁned as the time of the ﬁrst positive blood culture), were
recorded. The presence of known risk factors for CoNS
sepsis [6–9] was also noted. The clinical proﬁle of the neo-
nates was evaluated on the basis of clinical manifestations at
the onset of the septic episode, which included temperature
instability (rectal temperature of <36.5C or >37.5C), respi-
ratory deterioration (increased number of oxygen desatura-
tions, increase in oxygen requirement, need for ventilatory
support, and increased number of apnoeas), circulatory
deterioration (hypotension and signs of peripheral hypo-
perfusion), and feeding intolerance (abdominal distension or
signiﬁcant aspiration of gastric residue that required a
decrease of >20% or cessation of feeding for at least 24 h).
The duration of the septic episode was also noted.
The minimum platelet count during the septic episode was
recorded. A platelet count of <80 · 109/L was deﬁned as
thrombocytopenia, whereas a platelet count of <30 · 109/L
was deﬁned as severe thrombocytopenia, according to the
protocols of our NICU. C-reactive protein (CRP) values at
the onset of sepsis, maximum CRP levels during the septic
episode and the time from the onset of sepsis to the maxi-
mum CRP levels were also evaluated.
According to the protocols of our NICU, all neonates with
suspected late-onset sepsis had a full sepsis work-up (includ-
ing blood, urine and cerebrospinal ﬂuid cultures) and were
initially treated with an antibiotic regimen containing vanco-
mycin. The vancomycin dose was adjusted to achieve a trough
serum concentration within the therapeutic range (5–10 lg/
mL). After the third consecutive positive blood culture, cen-
tral catheters were removed and rifampicin was added to the
antibiotic regimen. Blood cultures and laboratory evaluation
were performed in all patients at time intervals of approxi-
mately 48 h. In neonates with thrombocytopenia, platelet
counts were monitored daily, and patients received platelet
transfusions at a platelet count of <30 · 109/L. All neonates
with persistent bacteraemia were evaluated by echocardiogra-
phy (including examination of the great vessels), in order to
rule out any endocardiac septic focus.
Microbiological and molecular evaluation
Blood cultures were processed in the microbiology labora-
tory of our institution according to regular practice, into
BacT/ALERT PF paediatric FAN vials of the BacT/ALERT 3D
system for aerobic and anaerobic bacteria (bioMe´rieux SA,
Marcy l’ Etoile, France). Coagulase-negative staphylococci
were identiﬁed on the basis of colony morphology, Gram
stain, and positive catalase and negative coagulase test results
(Slidex Staph Plus; bioMe´rieux). Species identiﬁcation was per-
formed with the VITEK 2 System (bioMe´rieux). When pheno-
typic identiﬁcation showed efﬁcacy lower than 99%, a
molecular method based on the tuf gene was applied [21].
Tests for susceptibility to antistaphylococcal agents were per-
formed by the disk diffusion method and Etest (AB Biodisk,
Solna, Sweden), according to CLSI guidelines [22]. Clones
were deﬁned by pulsed-ﬁeld gel electrophoresis (PFGE) of
SmaI DNA digests, performed as previously described, and
types were assigned according to well-deﬁned criteria [23,24].
Bioﬁlm production was tested by a qualitative method car-
ried out in glass test tubes, as previously described [25].
Ampliﬁcation of two genes of the ica operon (icaA and icaD)
and the mecA gene (encoding penicillin-binding protein 2a,
conferring resistance to methicillin) was performed by PCRs
with speciﬁc primers, according to previously described
protocols [26,27].
Statistical analysis
Comparisons of demographic data, risk factors, clinical pro-
ﬁles and laboratory indices between neonates with persistent
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and those with non-persistent CoNS bacteraemia were per-
formed with the Mann–Whitney U-test or v2-test, where
appropriate. Risk variables that displayed considerable differ-
ences on exploratory analysis were evaluated by logistic
regression to examine their joint effect on the risk of persis-
tent bacteraemia. In order to correlate the clinical risk pro-
ﬁle of each neonate with the underlying molecular CoNS
characteristics, a case was labelled as bioﬁlm-positive if at
least one bioﬁlm-producing isolate was identiﬁed in the ﬁrst
or/and second positive blood culture. The bioﬁlm phenotype
was also included in the logistic regression model. The
Hosmer–Lemeshow test was used to test the ﬁnal model for
goodness-of-ﬁt. Statistical analyses were performed with
SPSS 17.0 (SPSS, Chicago, IL, USA).
Results
During the 2-year period, 72 neonates with late-onset CoNS
sepsis (8.5% of all NICU admissions) were identiﬁed. Of
these, 29 cases had persistent and 43 non-persistent CoNS
bacteraemia. There were no differences between the persis-
tent and non-persistent group regarding the postnatal age at
the onset of sepsis (median 8 days, range 4–45 days vs.
median 9 days, range 4–30 days, respectively, p 0.438). The
median duration of bacteraemia in the persistent group was
10 days (range 7–17 days), as compared with 2 days (range
2–5 days) in the non-persistent group.
There were no signiﬁcant differences regarding demo-
graphic and clinical characteristics between the two groups
(Table 1). The presence of an endotracheal tube and central
indwelling catheters was more frequently noted in neonates
with persistent CoNS bacteraemia. These neonates had also
higher maximum CRP levels, which also peaked at shorter
time intervals. The incidence of thrombocytopenia was signif-
icantly higher in the persistent group (Table 1).
A total of 170 bacterial isolates were identiﬁed (Table 2).
An average of 3.3 isolates per patient was identiﬁed in the
group with persistent CoNS bacteraemia, and an average
of 1.7 isolates per patient in the group with non-persistent
TABLE 1. Comparison of different
characteristics between neonates
with persistent and those with
non-persistent coagulase-negative
staphylococcal bacteraemia
Persistent
(n = 29)
Non-persistent
(n = 43) p
Demographics
Male sex 16 (55.2) 25 (58.1) NSa
Gestational age (weeks) 32 (26–38) 33 (25–38) NSb
Birthweight (g) 1940 (1000–3750) 2200 (860–3270) NSb
Clinical practice risk factors
Intubation 16 (55.2) 12 (27.9) 0.027a
Central indwelling catheters 18 (62.1) 15 (34.9) 0.031a
Parenteral nutrition 17 (58.6) 24 (55.8) NSa
Histamine receptor 2 blockers 3 (10.3) 4 (9.3) NSa
Clinical characteristics
Temperature instability 24 (82.2) 28 (65.1) NSa
Food intolerance 19 (65.5) 21 (48.8) NSa
Respiratory deterioration 14 (48.3) 16 (37.2) NSa
Circulatory deterioration 19 (65.5) 22 (51.2) NSa
Laboratory indices
Minimum platelet count (·109/L) 29 (12–110) 148 (43–577) <0.001b
Thrombocytopenia (<80 · 109/L) 27 (93.1) 10 (23.3) <0.001a
Severe thrombocytopenia (<30 · 109/L) 22 (75.9) 3 (7.0) <0.001a
CRP at onset (mg/dL) 1.3 (0.4–16) 1.1 (0.2–16) NSb
Maximum CRP (mg/dL) 8.9 (0.5–26.9) 4.0 (0.5–23.1) 0.012b
Days up to maximum CRP 2 (1–5) 3 (1–5) <0.001b
CRP, C-reactive protein; NS, not signiﬁcant.
Data are presented as number of cases (%) or medians (range) where appropriate.
av2-test; bMann–Whitney U-test.
TABLE 2. Number of patients and isolates per coagulase-negative staphylococcal species
Organism
Persistent group (n = 29) Non-persistent group (n = 43) Total (n = 72)
No. of
neonates
No. of
isolates (%)
No. of
neonates
No. of
isolates (%)
No. of
neonates
No. of
isolates (%)
S. epidermidis 18 57 (60.8) 24 40 (57.5) 42 97 (59.4)
S. haemolyticus 16 35 (34.0) 13 24 (28.8) 29 59 (31.8)
S. hominis 3 3 (3.1) 6 6 (9.6) 9 9 (5.9)
S. warneri 1 1 (1.0) 1 1 (1.4) 2 2 (1.2)
S. lugdunensis 1 1 (1.0) 1 1 (1.4) 2 2 (1.2)
S. saprophyticus – – 1 1 (1.4) 1 1 (0.6)
Total isolates 97 73 170
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bacteraemia. Staphylococcus epidermidis was the most preva-
lent organism (Table 2). Twenty-ﬁve distinct PFGE types
were identiﬁed. Ten (A, B, C, F, H, M, P, U, V, and Z) were
found in both groups, whereas eight (E, G, K, Q, R, S, T, and
Y) were unique for the persistent group, and seven (D, I, J,
N, O, W, and X) were unique for the non-persistent group.
The distribution of predominant clones (A, B, C, and H) was
similar between the two groups (p 0.511; Fig. 1). PFGE types
and bioﬁlm production per CoNS species are presented in
Appendix 1. All but three isolates were resistant to methicil-
lin (98% mecA-positive); all isolates were susceptible to
vancomycin (MICs £2 mg/L).
Speciﬁc molecular characteristics of the isolates are pre-
sented in Table 3. Bioﬁlm production was shown by 80 iso-
lates (47.1%); 54 of these were isolated from neonates with
persistent and 26 from neonates with non-persistent bacter-
aemia (p 0.013; Fig. 1). In the persistent group, 21 (38.9%) of
the bioﬁlm-producing isolates were obtained after the third
positive blood culture, despite removal of central catheters.
Among all the isolates, 127 (74.7%) were positive for the ica
operon. The presence of ica genes was not related to persis-
tent CoNS bacteraemia (Table 3). Sixty (35.3%) ica-positive
iolates did not produce slime, whereas 13 (7.6%) ica-negative
isolates showed bioﬁlm formation.
Thirty-seven cases were classiﬁed as bioﬁlm-positive; 21
of these were diagnosed with persistent and 16 with non-
persistent CoNS bacteraemia. The effect of endotracheal
intubation, the presence of central indwelling catheters at
the onset of sepsis and the presence of bioﬁlm-producing
isolates on the risk of persistent CoNS bacteraemia is analy-
sed in Table 4. Although, when tested separately, each of
these risk factors was signiﬁcantly related to persistent
FIG. 1. Distribution of pulsed-ﬁeld gel elec-
trophoresis (PFGE) types with bioﬁlm pro-
duction in the persistent and non-persistent
groups of bacteraemia. *Non-predominant PF-
GE types: E, F, G, K, M, P, Q, R, S, T, U, V, Y
and Z in the persistent group, and D, F, I, J,
M, N, O, P, U, V, W, X and Z in the non-per-
sistent group.
TABLE 3. Speciﬁc molecular coag-
ulase-negative staphylococcal phe-
notypes in the persistent and
non-persistent groups
Total
(n = 170)
Persistent
bacteraemia
(n = 97)
Non-persistent
bacteraemia
(n = 73) p
ica-positive 127 (74.7) 74 (76.3) 53 (72.6) 0.598a
Bioﬁlm-positive 80 (47.1) 54 (55.7) 26 (35.6) 0.013a
ica-positive/bioﬁlm-positive 67 (39.4) 44 (45.4) 23 (31.5) 0.082a
ica-positive/bioﬁlm-negative 60 (35.3) 30 (30.9) 30 (41.1) 0.196a
ica-negative/bioﬁlm-negative 29 (17.1) 13 (13.4) 16 (21.9) 0.155a
ica-negative/bioﬁlm-positive 13 (7.6) 10 (10.3) 3 (4.1) 0.156a
Data are presented as numbers of cases (%).
av2-test.
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bacteraemia, only bioﬁlm production was ﬁnally identiﬁed as
a major determinant of the persistent form of the disease in
a stepwise logistic regression model (Table 4). The model
showed no evidence of lack of ﬁt based on the Hosmer–
Lemeshow statistic (v2 9.32, degrees of freedom 6, p 0.156).
Discussion
We evaluated the clinical and microbiological proﬁle of a
more aggressive pattern of neonatal CoNS sepsis, character-
ized by persistent bacteraemia with overt signs of septicae-
mia despite antibiotic therapy. To our knowledge, this is the
ﬁrst study aimed at analysing the joint effect of speciﬁc clini-
cal factors and the CoNS microbiological and molecular
proﬁle on the risk of persistent bacteraemia in neonates
requiring intensive care.
In a similar outbreak of CoNS sepsis in the NICU, the
presence of central indwelling catheters was more frequently
noted in neonates with persistent bacteraemia [13]. Molecu-
lar analysis of S. epidermidis isolates from that outbreak
revealed that there was no association between the presence
of the ica operon and bioﬁlm formation, and that isolates
related to persistent bacteraemia were not more competent
at producing bioﬁlm [20]. A similar lack of an association
between the presence of the ica operon and quantitative bio-
ﬁlm production has been reported previously [19], although
CoNS isolates associated with disease in this study were
more likely to produce bioﬁlm.
The incidence of persistent bacteraemia in our series was
40.3%, which is comparable to the 48% reported previously
[13]. Extreme prematurity and very low birthweight have
been recognized as important risk factors for CoNS bactera-
emia in NICU settings [5–9]. In our study, the demographic
proﬁles of the neonates were similar between the persistent
and non-persistent groups, suggesting that these factors were
not related to the persistent pattern of the disease. Despite
the remarkable percentage of neonates with persistent bac-
teraemia and overt signs of septicaemia, the mortality rate
during the septic episodes in our series was zero. This ﬁnd-
ing probably reﬂects the relatively benign course of CoNS
sepsis in comparison with other pathogens [2,7,10–13].
On exploratory analysis, endotracheal intubation and the
presence of central vascular catheters seemed to be impor-
tant risk factors for persistent CoNS sepsis. However,
approximately 38% of the neonates with persistent bactera-
emia did not have a central vascular catheter. Moreover,
among neonates with non-persistent bacteraemia, approxi-
mately 28% were intubated and 35% had a central catheter
at the onset of sepsis. These ﬁndings are in agreement with
previous reports [7,13]. When the joint effect of the pres-
ence of central catheters, endotracheal intubation and bioﬁlm
production was evaluated, the only signiﬁcant ﬁnding was
related to bioﬁlm production. These results suggest that risk
factors related to clinical practice may have been responsible
for establishing the infection, but other factors related to
CoNS virulence (i.e. bioﬁlm production) were involved in its
persistence. Although prolonged parenteral nutrition has
been also recognized as an important risk factor for CoNS
sepsis in the NICU [8,9], it was not related to persistent
bacteraemia in the present study.
The remarkable incidence of severe thrombocytopenia in
our persistent group was consistent with previous reports
[13], suggesting that it may represent a common characteris-
tic of the atypical CoNS sepsis. Another ﬁnding was the dif-
ference in the CRP kinetics, as the magnitude and the rate of
the CRP increase were both signiﬁcantly higher in neonates
with persistent CoNS bacteraemia.
In agreement with previous reports [20], no signiﬁcant
difference in the distribution of the ica operon between the
persistent and the non-persistent groups was found. Moreover,
there was no signiﬁcant difference in regard to the distribution
of the bioﬁlm/ica combination. Approximately 35% of the iso-
lates were bioﬁlm-negative, although carrying the ica operon,
suggesting that it may be the regulation of bioﬁlm expression
rather than the presence of the ica operon that is involved in
bacterial virulence [19,20]. Another important ﬁnding was the
identiﬁcation of bioﬁlm-positive/ica-negative isolates. Although
this could demonstrate the need to study the presence of
surface adhesins contributing to bioﬁlm formation, identiﬁca-
tion of bioﬁlm-positive/ica-negative isolates has also been
recently reported in paediatric [28] and adult patients [29,30].
These isolates, which have been shown to exhibit more toler-
ance to vancomycin than the bioﬁlm-positive/ica-positive phe-
notype [29], could represent an emerging subpopulation of
TABLE 4. Effect of endotracheal intubation, presence of
central vascular catheters and bioﬁlm production on
the risk of persistent coagulase-negative staphylococcal
bacteraemia
Independent effect Joint effect
cOR p aOR (95% CI) p
Intubation 2.84 (1.07–7.56) 0.037 2.06 (0.65–6.56) 0.222
Central indwelling
catheters
3.06 (1.15–8.12) 0.025 2.42 (0.77–7.67) 0.132
Bioﬁlm productiona 4.43 (1.60–12.31) 0.004 4.69 (1.59–13.84) 0.005
aOR, adjusted odds ratio; cOR, crude odds ratio.
Binary logistic regression analyses included 72 neonates. Adjusted estimates
were generated by controlling for the effects of each other of the factors.
aDeﬁned as the presence of bioﬁlm-producing strains in the ﬁrst and/or second
positive blood culture.
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coagulase-negative staphylococci under antibiotic selection
pressure on entering the hospital milieu.
Our study has some limitations that should be noted. Only
the icaA and icaD genes were investigated, in order to ascer-
tain the presence of the ica operon. Although these two
genes have been considered to be reliable markers of the ica-
positive genotype, we cannot rule out the existence of other
ica homologues that could not be identiﬁed in our study by
the primers used. In addition, staphylococcal surface proteins,
which promote adhesion and are important for cellular inter-
actions inﬂuencing bioﬁlm formation, were not investigated in
our population. Another limitation is that we were unable to
include the length of culture incubation, although the time of
positivity of the ﬁrst positive blood culture has been reported
to be signiﬁcantly shorter in neonates with persistent CoNS
sepsis [13]. Finally, we cannot rule out the possibility of an
endovascular septic focus, which could be responsible for the
persistence of bacteraemia, that cannot be detected with the
standard echocardiographic examination.
In conclusion, in the present study, the incidence of per-
sistent CoNS bacteraemia in neonates requiring intensive
care was remarkable, and it was associated with severe
thrombocytopenia. Isolates associated with persistent bacter-
aemia were more likely to produce bioﬁlm, independently of
the presence of the ica operon. Moreover, bioﬁlm produc-
tion was the most signiﬁcant risk factor for persistent CoNS
bacteraemia, independently of other known clinical risk
factors. Our ﬁndings suggest that, in NICUs, it may be the
regulation of bioﬁlm expression, rather than the presence of
ica genes, that is involved in bacterial virulence.
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APPENDIX 1: Pulsed-ﬁeld gel electrophoresis (PFGE) types and bioﬁlm production per coagulase-negative staphylococcal
(CoNS) species
CoNS species No.
PFGE type
A B C D E F G H I J K M N O P Q R S T U V W X Y Z
S. epidermidis Total 97 59 14 11 2 2 1 3 2 1 2
Slime + 60 37 8 11 1 1 1 1 – – –
S. haemolyticus Total 59 5 2 5 40 3 2 2
Slime + 18 1 – 2 11 2 – 2
S. hominis Total 9 2 3 1 2 1
Slime + 1 – – – 1 –
S. lugdunensis Total 2 2
Slime + 1 1
S. warneri Total 2 2
Slime + – –
S. saprophyticus Total 1 1
Slime + – –
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